Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Fosrolapitant and Palonosetron Hydrochloride for Injection
- Product Name
- 瑞坦宁
- Approval Number
- 国药准字H20250027
- Approval Date
- May 27, 2025
NMPA
Hemofiltration Replacement Fluid of Sodium Citrate
- Product Name
- 枸橼酸钠血滤置换液
- Approval Number
- 国药准字H20254278
- Approval Date
- May 27, 2025
NMPA
Compound Amino Acid (16AA), Glucose (12.6%) and Electrolyte Injection
- Product Name
- 复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液
- Approval Number
- 国药准字H20253130
- Approval Date
- Jan 14, 2025
NMPA
10% Fat Emulsion (OO)/5.5% Amino Acids (15)/Glucose (20%) Injection
- Product Name
- 10%脂肪乳(OO)/5.5%氨基酸(15)/葡萄糖(20%)注射液
- Approval Number
- 国药准字H20234621
- Approval Date
- Dec 13, 2023
NMPA
Paracetamol and Mannitol Injection
- Product Name
- 对乙酰氨基酚甘露醇注射液
- Approval Number
- 国药准字H20223028
- Approval Date
- Jan 30, 2022
NMPA
Sodium Potassium and Glucose Injection
- Product Name
- 钠钾葡萄糖注射液
- Approval Number
- 国药准字H20217008
- Approval Date
- Jan 14, 2021
NMPA
Sodium Potassium and Glucose Injection
- Product Name
- 钠钾葡萄糖注射液
- Approval Number
- 国药准字H20217007
- Approval Date
- Jan 14, 2021
NMPA
Clinical Trials
No trials found
News
No news found